Syra Health Corp. Class A Stock (NASDAQ:SYRA)


RevenueFinancialsChart

Previous Close

$0.51

52W Range

$0.05 - $0.70

50D Avg

$0.45

200D Avg

$0.18

Market Cap

$5.84M

Avg Vol (3M)

$67.25K

Beta

3.56

Div Yield

-

SYRA Company Profile


Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

57

IPO Date

Sep 29, 2023

Website

SYRA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Population Health$5.32M$312.00K$715.50K
Health Education--$12.31K

Fiscal year ends in Dec 25 | Currency in USD

SYRA Financial Summary


Dec 25Dec 24Dec 23
Revenue$7.23M$7.98M$5.52M
Operating Income$-904.32K$-3.76M$-2.89M
Net Income$-896.33K$-3.76M$-2.94M
EBITDA$-904.32K$-3.68M$-2.84M
Basic EPS-$-0.52$-0.60
Diluted EPS-$-0.52$-0.60

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 25May 11, 25 | 9:00 AM
Q4 24Mar 11, 25 | 9:00 AM
Q1 24May 12, 24 | 9:00 AM

Peer Comparison


TickerCompany
XAGELongevity Health Holdings Inc.
IVFINVO Fertility, Inc.
PIIIP3 Health Partners Inc.
WORXSCWorx Corp.
SISIShineco, Inc.
BACKIMAC Holdings, Inc.
CDTCDT Equity Inc.
PTPIPetros Pharmaceuticals, Inc.
CCMConcord Medical Services Holdings Limited